Categories
Berkshire Hathaway Specialty Insurance Insurance

Berkshire Hathaway Specialty Insurance Expands into Transactional Liability Insurance in UK & Europe

(BRK.A), (BRK.B)

Berkshire Hathaway Specialty Insurance (BHSI) is expanding its North American Transactional Liability Insurance business into the UK and Europe and has appointed Ed Martin as Head of Transactional Liability, UK and Europe.

“As the need for solutions for the risks and uncertainties in corporate transactions continues to grow, BHSI is pleased to bring to market the local expertise, financial strength, and capacity that will enable companies in the UK and throughout Europe to respond, quickly and strategically, to the exposures of mergers, acquisitions and other transactions,” said Robert Underhill, Senior Vice President, Head of Transactional Liability, BHSI. “Ed is a stellar addition to our expanding Transactional Liability team worldwide.”

“Our capabilities in the UK, throughout Europe and around the world continue to expand to help our customers respond to pressing risks,” said Chris Colahan, Head of UK and Europe, BHSI. “This latest expansion follows the well set pattern of BHSI’s growth: We grow where and when we can offer outstanding expertise and provide meaningful long-term solutions, backed by our stable capacity and financial strength.”

BHSI will provide Warranty and Indemnity, Tax, and Contingent Liability Insurance in the UK and throughout Europe. The company also provides Representations & Warranties, Contingent Liability, and Class Action Settlement Insurance in the U.S. and Canada.

Martin joins BHSI from global legacy and run-off specialist Enstar Group Limited. At Enstar, Ed was the lead in-house M&A lawyer working alongside Enstar’s dedicated M&A team. Prior to joining Enstar, Ed was Of Counsel at Norton Rose (now Norton Rose Fulbright) with their London Corporate and Regulatory Insurance team. Ed qualified as a lawyer in England and Wales in 2000.

Martin will be based in BHSI’s office in London.

© 2019 David Mazor

Disclosure: David Mazor is a freelance writer focusing on Berkshire Hathaway. The author is long in Berkshire Hathaway, and this article is not a recommendation on whether to buy or sell the stock. The information contained in this article should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future results.